All News

Short-term investments pertaining to the distribution of PrEP are expected to result in long-term cost-savings and promote significant health benefits following its introduction in Germany, according to a new modelling study.

Hematological consequences of severe chronic neutropenia vary based on the underlying etiology of the condition, according to a study abstract presented at the 60th American Society of Hematology Annual Meeting & Exposition.

Since carfilzomib was approved at a 27 mg/m2 twice-weekly dose, it has since been optimized at 56 mg/m2 twice-weekly and a recent study found benefits of a 70 mg/m2 once-weekly dose. However, most patients are still treated with the original approval dosage, suggesting they might be undertreated.

This week, the top managed care news included pharmaceutical executives appearing before a Senate drug pricing hearing; HHS finalizing a Title X rule change; and an analysis that found travel and wait times for healthcare services come with a high price.

Scientists at the National Institutes of Health have recently found that biologic age, or a DNA-based estimate of a person’s age, is associated with future development of breast cancer.

Nearly 10% of drug approvals in 2018 were generic products for branded drugs that had no FDA-approved generics.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Senator Bill Cassidy, R-Louisiana, is working with Democratic colleagues Michael Bennet of Colorado and Maggie Hassan of New Hampshire to introduce a bill this month to stop patients from getting surprise medical bills; the FDA warned a major Canadian drug distributor, CanaRx to stop selling unapproved and mislabeled medicines to Americans looking to save money on prescriptions; Democratic leaders in the House of Representatives are trying to keep the chamber united behind narrower proposals aimed at strengthening the Affordable Care Act and lowering drug prices in the wake of the introduction of a Medicare for All bill.

The vast majority of patients with COPD require greater motivation to seek help when symptom changes occur and are unaware of their increased risk of developing lung cancer, according to new research.

How to improve patient-reported measurement in oncology valued-based care is the focus of a new report from The National Pharmaceutical Council and Discern Health.

Here are 5 interesting findings from the February 2019 issue of AJMC®.

Between 2014 and 2017, antivirals were consistently the number 1 most costly outpatient drug group for Medicaid, and HIV antiretrovirals and hepatitis C drugs accounted for more than 90% of spending on these antivirals.

A webinar presented by the Patient-Centered Primary Care Collaborative emphasized the issues that women continue to face regarding fairness and equality in modern healthcare, discussing topics such as caregiving, maternal and mental health, racial disparities, and more.

A new study determines the smallest change in upper extremity function that patients with multiple sclerosis (MS) find important or meaningful through an analysis in the change of scores of the Arm Functiom in Multiple Sclerosis Questionnaire.

Researchers have confirmed that there is no link between flu shots and miscarriages; a liquid biopsy is as effective as tissue-based testing for identifying treatment for lung cancer; and physicians generate an average of $2 million a year for hospitals.

Here are the top 5 articles for the month of February.

During the hearing on drug pricing held yesterday before the US Senate Committee on Finance, 7 pharmaceutical executives gave testimony in an effort to explain rising drug costs in the United States and offer solutions to lower them.

According to a new study, migraine is associated with a higher risk of open-angle glaucoma compared with patients with no migraine.

House Democrats are expected to introduce a Medicare for All bill today; CMS' Center for Medicare and Medicaid Innovation is planning to unveil a new payment model for primary care physicians; and CMS, CDC, and FDA have established a task force to improve future responses to public health emergencies.

Areas such as physical health showed improvement, but career and social well-being continue to weaken for Americans.

Patients with metastatic castration-resistant prostate cancer (mCRPC) have a lower risk of developing grade 3 or 4 neutropenia, likely due to less exposure to docetaxel.

Hospitals nationwide continued to snap up medical practices, according to updated figures about acquisition trends and the impact on physician employment.

Both travel and wait times for healthcare services are longest when compared with other services, such as getting a license or a vehicle repaired.

A high proportion of patients with acute myeloid leukemia (AML) who achieve a negative minimal residual disease (MRD) status still relapse, indicating a more sensitive method of detecting MRD is needed.

New Mexico, Colorado, Oregon, Washington, and Minnesota are among states looking at “Medicaid buy-in” proposals as a way to offer more affordable healthcare options; the return of measles is creating a backlash against critics of vaccines; first responders who worked during and after the 9/11 terror attacks and their advocates urged Congress to ensure that the September 11th Victim Compensation Fund does not run out of money.

The study followed a directive from CMS to screen dialysis patients for depression and develop a follow-up plan for care for those diagnosed.

Research from 2008 to 2014 suggests that vaccinations have been successful in preventing the most dangerous strains of HPV that cause nearly 70% of cervical cancer.

The grilling that pharmaceutical company executives are expected to face Tuesday before the Senate Finance Committee is reminiscent of previous hearings with businesses that proved to be turning points; UnitedHealthcare lost its case to prevent a former executive from working at the new healthcare venture formed by Amazon, Berkshire Hathaway, and JPMorgan Chase; a bill to establish work requirements for thousands of Medicaid recipients in Wyoming passed its first reading in the state’s House.